← SynDRA
NELFINAVIR
SynDRA canonical compound SYN0000959 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | CYP3A4 |
| Mechanism of action | HIV protease inhibitor |
| Indication | human immunodeficiency virus (HIV-1) |
| Disease area | infectious disease |
All known targets
- CYP3A4
- CYP2C9
- CYP3A7
- CYP1A2
- CYP2B6
- CYP2C19
- CYP2D6
- OPRD1
- OPRK1
- OPRM1
- PGR
- SLC6A2
Mechanisms of action (all sources)
- protease inhibitor
- pol INHIBITOR
Drug classes
- HIV Protease Inhibitors
- Protease Inhibitor
- Cytochrome P450 3A Inhibitors
- Anti-HIV Agents
- Anti-Infective Agents
- Anti-Retroviral Agents
- Antiviral Agents
- Enzyme Inhibitors
- Protease Inhibitors
- Viral Protease Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- viracept
- nelfinavir mesylate
- nelfinavir mesilate
- NSC-747167
- VRX496
- Viracept
- Nelfinavir [INN:BAN]
- AG1343
- UNII-HO3OGH5D7I
- AG 1343
- C32H45N3O4S
- NELFINAVIR MESYLATE AG1343
- Viracept (TN)
- HO3OGH5D7I
- CHEBI:7496
- NLF
- 1UN
- 2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-4-PHENYL SULFANYL-BUTYL]-DECAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID TERT-BUTYLAMIDE
- (3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide
- NFV
- Nelfinavir Monomethane Sulfonate
- AG1346
- Nelfinavir (INN)
- Nelfinavir [BAN:INN]
- AG1343 (*Mesylate salt*)
- Viracept (TM)(*Mesylate salt*)
- Met-SDF-1beta & Nelfinavir
- Met-Stromal Cell-derived Factor-1beta (Human) & Nelfinavir
- (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
- NSC 747167
- nelfinavirum
- RefChem:57161
- DTXCID3015080
- J05AE04
- AG-1343
- AG1341
- MFCD01938163
- NELFINAVIR [INN]
Reported adverse events
- Nausea
- Rash
- Flatulence
- Leukopenia
Look up NELFINAVIR in the interactive SynDRA portal →